MACrO2 is a clinical research study for people with Mycobacterium avium complex (MAC) lung disease. The study is researching epetraborole, which may be able to help fight the bacteria that cause MAC lung disease.
Study participation lasts between 6 to 18 months. If you join the study, you will be asked to do the following:
Know that you can stop participating in a clinical research study at any time, for any reason.
You may be eligible to join MACrO2 if you meet the following criteria*:
*Other criteria apply.
Talk to your doctor or reach out to a study site near you to learn if you may be eligible.